Chevy Chase Trust Holdings, Inc. Maxcyte, Inc. Transaction History
Chevy Chase Trust Holdings, Inc.
- $30.3 Billion
- Q1 2024
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 1,296,397 shares of MXCT stock, worth $5.08 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,296,397
Previous 56,795
2182.59%
Holding current value
$5.08 Million
Previous $266,000
1941.73%
% of portfolio
0.02%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MXCT
# of Institutions
126Shares Held
62MCall Options Held
2.4KPut Options Held
2.1K-
Black Rock Inc. New York, NY7.23MShares$28.3 Million0.0% of portfolio
-
Cadian Capital Management, LP New York, NY6.56MShares$25.7 Million0.98% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.17MShares$24.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$21 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$19.8 Million6.7% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $399M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...